Lichtenstein D R, Carr-Locke D L
Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Gastrointest Endosc Clin N Am. 1995 Jan;5(1):237-58.
Mucinous pancreatic neoplasms present diagnostic and therapeutic challenges. These tumors behave in an indolent nature, with frequent overlap of symptoms and radiographic appearance with other forms of pancreatic cysts, pseudocysts, and malignancy. Some authors propose that all mucin-producing tumors of the pancreas are variants of the same basic entity and have subclassified them on the basis of their predominant location within the pancreas. These disorders must be considered in the evaluation of chronic abdominal pain, particularly in the presence of a cystic pancreatic lesion or when associated with idiopathic chronic or acute recurrent pancreatitis. The clinicopathologic features of IMHN overlap to a great extent with classic mucinous cystic neoplasms but are different significantly enough to be distinct clinical entities. These tumors originate from the pancreatic duct epithelium, produce mucin, demonstrate a papillary growth pattern, and are considered premalignant or frankly malignant at the time of diagnosis. Both lesions biologically are much less aggressive than that of pancreatic ductal adenocarcinoma and appear to infiltrate peripancreatic tissue and to metastasize to lymph nodes or other adjacent structures late in the course of disease. Nevertheless, IMHNs are located primarily in the head of the pancreas, commonly affect elderly men, and present clinically with obstructive pancreatitis, often leading to pancreatic insufficiency, whereas mucinous cystic neoplasms are more likely to develop in the pancreatic body or tail, predominate in young women, and present with symptoms referable to tumor compression of adjacent structures. The location of the lesion is the primary differentiating feature because the lining epithelium of the two tumor types is indistinguishable pathologically. In mucinous cystic tumors, the mucus is secreted and retained within the cyst lumen because of the absence of communication between the cyst and the main pancreatic duct. In contrast, mucus produced in MDE flows into the main pancreatic duct, resulting in obstructive pancreatitis and, ultimately, dilatation of the pancreatic duct. Intraductal mucus provides an important clue to the diagnosis of intraductal pancreatic neoplasms and, whenever present, should prompt an aggressive diagnostic evaluation. Both lesions are managed by resectional surgery because the opportunity for cure is high in the absence of metastatic disease.
黏液性胰腺肿瘤在诊断和治疗方面存在挑战。这些肿瘤生长缓慢,其症状和影像学表现常与其他类型的胰腺囊肿、假性囊肿及恶性肿瘤重叠。一些作者认为,胰腺所有产生黏液的肿瘤都是同一基本实体的变体,并根据其在胰腺内的主要位置对其进行了亚分类。在评估慢性腹痛时,必须考虑这些疾病,尤其是在存在胰腺囊性病变或与特发性慢性或急性复发性胰腺炎相关时。IMHN的临床病理特征在很大程度上与经典黏液性囊性肿瘤重叠,但又有足够明显的差异,从而成为不同的临床实体。这些肿瘤起源于胰腺导管上皮,产生黏液,呈乳头状生长模式,在诊断时被认为是癌前病变或已发生恶变。这两种病变在生物学行为上都远不如胰腺导管腺癌侵袭性强,似乎在疾病后期才浸润胰腺周围组织并转移至淋巴结或其他邻近结构。然而,IMHN主要位于胰头,常见于老年男性,临床上表现为梗阻性胰腺炎,常导致胰腺功能不全,而黏液性囊性肿瘤更易发生于胰体或胰尾,以年轻女性为主,表现为肿瘤压迫邻近结构引起的症状。病变位置是主要的鉴别特征,因为这两种肿瘤类型的内衬上皮在病理上难以区分。在黏液性囊性肿瘤中,由于囊肿与主胰管之间缺乏连通,黏液分泌并潴留在囊腔内。相比之下,MDE产生的黏液流入主胰管,导致梗阻性胰腺炎,最终引起胰管扩张。导管内黏液是诊断导管内胰腺肿瘤的重要线索,一旦出现,应促使进行积极的诊断评估。这两种病变均通过手术切除进行治疗,因为在没有转移性疾病的情况下治愈的机会很大。